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Despite the fact that skeletal stem cell tissue engineering (TE) approaches 
appear promising, these approaches have not yet efficiently translated into 
large-scale clinical practice. Accordingly, although considerable research has 
been devoted to the development of stem cell orthopedic grafts, rather less 
attention has been paid to the optimization of the biofunctionalization of these 
grafts associated with their regeneration capacity, resulting usually in a 
random spatial distribution of the cells on the graft and suboptimal diffusion 
properties. Interpreting the evidence, more integrative studies where multi-
factorial experimental settings may closer resemble the in-vivo scenario, might 
be needed to enhance translational impact and accelerate bridging the gap 
from bench-to-bedside. 
By delivering a high level of tunable control over the microarchitecture of 
a graft, three dimensional (3D) printing TE technology appears able to extend 
its scope beyond the control of graft’s boundaries, aligned to the rising trend 
of innovative scaffold designs. Such design-driven optimization studies can 
serve ideally an integrative developmental framework in the strict context of a 
clear plan where the effects of the design/geometrical parameters of the graft 
are not mixed with each other. Taken together as well as the manufacturing 
limitations of the technology, a respective study towards the optimization of 
the delicate and dynamic interplay of multiple biofunctionalization factors 
affected from topological features of the graft at the mesoscale, appears as a 




Therefore, following an integrative design-driven optimization approach in 
the strict context of a clear research plan, this study proposes a novel 3D 
computer-aided design (CAD) pattern and targets five objectives for the 
development of the prototype of an integrated 3D printed stem cell orthopedic 
graft. Additionally, the study isolates a primary adipose-derived stromal/stem 
cell population and suggests a further developmental pipeline comprised of 
experiments and respective materials, creating a complete design platform 
towards the future prototype to product development of the graft. 
Relative to the objectives of the study, in terms of commercialization, the 
minimal size of the CAD pattern appears able to allow the large scale 
personalized biofabrication of the graft. In terms of biological significance, the 
biomimetic spatial heterogeneity of the graft appears with potential to control 
cell positioning on the graft and guide vascularization. Additional “form-
follows-function” design micromechanisms in the design/manufacturing 
interface of 3D printing and microfluidics engineering, appear with potential 
to develop abilities for 3D cellular aggregation and oxygenation within the 
pores (artificial stem cell niches) of the graft, so as to maintain cell viability 
and facilitate the creeping substitution even in the centre of the graft at the 
early inflammatory stage that vascularization has not yet developed. The 
overall synergistic effect of the integrated design, especially within non-union 
clinical cases, is expected to enhance the overall regeneration capacity of the 
graft in the direction of a functional full-thickness bone healing outcome. 
Summarizing, new integrated design-driven optimization approaches not 




to enhance translational impact in the research field of 3D printing Tissue 
Engineering (TE). In this context, by developing the prototype of an integrated 
3D printed stem cell orthopedic graft according to a clear research plan where 
the effects of the design/geometrical parameters of the graft are not mixed 
with each other, this novel study argues the value of the integrated design-
driven optimization perspective, triggering the development of a toolkit of 
microarchitecture-performance relations designed to tailor the large scale 
personalised biofabrication ability and regeneration capacity of the graft. 
Additionally, the study isolates a primary adipose-derived stromal/stem cell 
population and suggests a further developmental pipeline, creating a complete 
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1. Literature review 
 
1.1. Intro – Clinical need 
Bone appears with a remarkable intrinsic property to regenerate and 
remodel spontaneously, however, it also appears that the critically sized bone 
defects are not subject to this spontaneous regeneration [1]. In these cases, the 
host cycle of bone repair appears insufficient and usually respective 
therapeutic applications require the assistance of bone grafts [2]. Of the 
millions of bone fractures occurring  annually, according to retrospective 
studies relative to tibial shaft fractures in the U.S.A. [3] and Canada [4], 
approximately up to 12 % and 18.5 % of cases respectively result in non-union 
[5]. Thus, a demand appears for more effective clinically applicable bone 
grafts able to address these cases, with enhanced regeneration capacity and 
tailored to fit in the fracture area.   
 
1.2. Rationale for more effective solutions (I); Development of optimized 
stem cell orthopedic grafts  
1.2.a. Why a stem cell orthopedic graft 
The development of more effective grafts requires a thorough 
understanding of the bone healing process, especially in cases that bone grafts 
are used within a respective therapeutic application [1, 2, 5]. Briefly, all types 
of bone grafts appear to integrate into host bone according to a common 
mechanism, where the grafts are gradually replaced with host tissue within a 
process which is called creeping substitution. Capillary networks that sprout 
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from surrounding tissues grow into the porous structure of the grafts and 
skeletal stem cells (mesenchymal stem cells “MSCs” or other osteoprogenitor 
cells) [6] stimulated by osteoinductive biomolecules differentiate into 
osteoblasts, forming mineralized clusters and producing new mineralized 
osteoid that is deposited either on the bone matrix, or on some other selected 
substrate designed for that reason (osteoconductive material). In a later stage, 
osteoclasts precursors appear to be recruited from the vascular system, where 
they differentiate so as to facilitate the physiologic remodeling of the graft into 
mature bone tissue (bone remodeling).  
Relative to the MSCs role, the MSCs appear to produce their tissue 
reparative role in two ways: a) either by contributing directly, differentiating 
into bone-forming osteoblasts in response to inductive powers and 
biomolecules, b) or by secreting soluble paracrine factors which target other 
molecular mechanisms and signalling 
pathways [7] [8]. The crosstalk between 
BMP and TGF-β signalling appears as the 
master regulator towards the differentiation 
of the MSCs in the osteoblastic lineage [9].  
Accordingly, strong evidence which 
appears as the guiding principle of the 
majority of the stem cell based TE studies, 
indicates that by modulating the stem cell 
niche, someone can modulate the function 













Fig. 1. Photo taken from [14]; 
bone healing outcome in rat 
animal model following 
engraftment of the same bone 
graft with (EPC) and without 
(Control) bio-functionalization 




fate [10]. Respective evidence especially within non-union cases [8, 11-13], 
including striking results (fig. 1) [14], indicates the development of stem cell 
orthopedic grafts (bone grafts bio-functionalized with stem cells) to enhance 
the healing process, maximizing the potential for a functional full thickness 
bone healing outcome.  
Escalating the justification for the development of optimized stem cells 
orthopaedic grafts, these grafts not only appear promising to address 
effectively non-union cases, but furthermore, evidence supports that one can 
envisage success within reach within the challenging clinical cases of 
craniofacial regeneration [15-17].  
 
1.2.b. Appropriate stem cells and stem cell sources; MSCs and ASCs 
Back in 1995, the first MSC clinical study used autologous culture-
expanded MSCs in patients with hematological malignancies, demonstrated no 
reports of adverse events. Since this first trial (21 years ago), over 3,000 
patients enrolled in over 100 clinical trials have met safety endpoints with no 
serious adverse events reported to date [18].  
More particularly, the potential of stem cells within bone regeneration 
applications appear well justified and MSCs appear with promising 
therapeutic potential for bone regeneration applications within animal and pre-
clinical studies [8, 19], interestingly even following systemic injection [20]. 
Within comparative studies including other cell types/populations with MSCs 
phenotypic expression which potentially can be used within bone regeneration 
applications (it appears a continuous increase of the stem cell sources that 
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might be proper for regenerative medicine applications), the comparison 
between MSCs derived from bone marrow (BMSCs) and MSCs derived from 
adipose tissue (ASCs) appear conflicting, with some studies to indicate similar 
osteogenic potential [21]. Other studies, including the comparison of human 
stem cells from other sources, like umbilical cord (hUCMSCs) and induced 
pluripotent stem cells (hiPSCs) [22], as well, embryonic stem cells (hESCs) 
and induced pluripotent stem cells (hiPSCs) [23], suggest that all these stem 
cells sources/types may be suitable for bone regeneration applications. Highly 
interestingly, in this direction, stem cell populations with MSCs phenotypic 
expression derived from amniotic fluid [24], human dental pulp [25] and blood  
[26, 27], appear able to differentiate towards the osteogenic lineage. 
Relative to the justification for the use of ASCs for the purposes of the 
current study (this study besides the development of a graft prototype, 
additionally, isolates a primary adipose-derived stromal/stem cell population 
and suggests a further developmental pipeline, towards the future prototype to 
product development of the graft), when ASCs are compared with BMSCs 
(BMSCs are usually used within bone regeneration applications), as 
mentioned above, ASCs appear also with justified osteogenic potential [11, 
28-30]. The major advantage of the ASCs compared to the BMSCs is that they 
appear abundant within the body and are easy to harvest from adipose tissues, 
without ethical concerns, following a minimally invasive tissue harvesting 
process (liposuction). Additionally, another reason for the selection of the 
ASCs is that evidence supports that they can be obtained without the 
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limitations of the age-related decline which appears in BMSCs [31] (the 
“aging” of stem cells appears with less impact on ASCs). 
 
1.2.c. Stem cell orthopedic applications and “Bio-functionalization” of the 
grafts; Methods and caveats 
Despite the well justified evidence and the fact that many orthopaedic 
surgeons have long appreciated the role of stem cell therapies within small 
scale clinical applications, these approaches have not yet efficiently translated 
into a large scale clinical practice [13, 18, 32]. Accordingly, although 
considerable research has been devoted in the last years to the development of 
stem cell orthopedic grafts [33, 34], there is rather a paucity of high level of 
evidenced studies [32], with less attention paid to the optimization of the bio-
functionalization of these grafts [35]. Thus, considering as well the natural 
bone structure (or other organ’s structure), where the different types of cells 
do not appear with a random distribution within the structure, but they appear 
well organized and aligned to the specific functions of the organ (e.g. 
osteoblasts forming clusters of mineralization during the osteogenesis 
progression and endothelial cells forming vasculature), the immersion of a 
graft in a stem cell hydrogel or the pipetting of stem cell suspensions on a 
graft by hand, which are the methods that orthopaedic surgeons use most 
frequently to load (“biofunctionalize”) grafts with stem cells, usually these 
methods result in a random spatial distribution of the cells on the graft [36] 
and suboptimal diffusion properties of the graft [33].  Accordingly, a recent 
study [37] which concluded that seeding a TE scaffold with cells using manual 
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injections appears more effective compared to the dripping protocol, indicates 
that more efficient respective strategies should be evolved.  
Before proceeding with the interpretation of the above contradiction that 
might lead to some insight able to drive the development of more effective 
(“optimized”) orthopedic grafts, especially within segmental fractures and 
non-union cases, it is needed to analyse first the usual practice that 
orthopaedic surgeons apply within these small-scale stem cell clinical 
therapies and the respective weakness that appears in the application of these 
therapies. Therefore, orthopaedic surgeons usually prefer to use a graft-stem 
cell carrier as the optimum solution to carry and localize the stem cells in the 
targeted fracture area, due to the fact that when the stem cells are mixed with 
other inductive biomolecules within a biodegradable/biocompatible hydrogel 
and injected directly in the body in the close vicinity of the fracture area, these 
injections appear unable to localize the stem cells in the fracture area and 
maintain their bioactivity (the combination of enzymatic and thermal activity 
in the fracture area affects negatively stem cells’ life span and bioactivity) [38]. 
But, even when a graft-stem cell carrier is been used to deliver the stem cells, 
a new caveat arises subject to the random distribution of the cells on the graft 
and the suboptimal diffusion properties of the graft. A non-uniform bone 
healing outcome may be developed in these cases, usually with a necrotic 
center and viable cells forming minimal bone tissue restricted to the graft’s 
boundaries [39]. The poor healing outcome in these cases appear even more 
challenging towards the need for the development of more effective grafts, 
especially when considering that cell-cell and cell–extracellular matrix 
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interactions appear within a highly dynamic microenvironment which provides 
several opportunities to interfere and drive stem cells’ behavior [10], including 
physical factors which hold key roles in bone development such as blood 
supply [40] and oxygen content [41].  
 
1.2.d. Scaffolding TE approaches to optimize a stem cell orthopedic graft; 
Address of bio-functionalization caveats and enhancement of 
regeneration capacity  
Conventional scaffolding TE methods appear currently with limitations in 
the fabrication of grafts able to answer the above clinical questions of 
controlling cell position on the graft and regulating the diffusion properties of 
the graft. Because these methods do not appear efficient to manufacture 
intricate geometries comprised of well-defined pores, structural integrity and 
effective interconnectivity between the pores, which are all design elements 
that appear able to regulate the biofunctionalization ability of the graft so as to 
address effectively the above issues [42]. Even in grafts fabricated with the 
newer and highly promising 3D printing TE technology using non cell-laden 
printing materials [43-45], the cells similarly appear with high difficulty to be 
seeded efficiently and placed in defined locations on the graft, as the 
technology appears to have tremendous potential, but still the printing 
outcome appears similar to the conventional TE techniques (the grafts 
produced with both TE techniques currently appear with similar properties). 
On the other hand, when cell-laden bioprinting approaches are used, the high 
stiffness of the cell-laden bioink which appears as a requirement for enhanced 
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“printability” (but with a negative impact in the viability of the cells), the 
generated heat and shear stress on the cells during hydrogel’s extrusion (which 
also appears with a negative impact in the viability of the cells) and the low 
cells’ seeding density of the cell-laden bioink which is suggested (high 
concentration of the cells in the cell-laden hydrogel appears to block the 
printing nozzle), all these compromise the efficiency of the highly promising 
cell-laden bioprinting approach [46]. Subsequently, when an advanced 
multidispenser extrusion printing system able to print concurrently synthetic 
polymers and cell-laden hydrogels is being used, one more caveat arises. If a 
slow cooling after the extrusion polymer has been selected, the viability of the 
cells in the interface of the cell-laden hydrogel and the slow cooling polymer 
may be compromised after the extrusion, due to the high temperatures. Thus, 
as the materials technological progress so far does not allow the selection of 
the synthetic polymer which will be used for printing within a wide range of 
materials, a rapid cooling after the extrusion polymer must be selected (the 
selection of PCL in these cases as a rapid cooling after the extrusion polymer, 
appears as an optimum material choice  [39]). 
 
1.3. Rationale for more effective solutions (II); Integration to enhance 
translational impact and accelerate translation 
Reverting in the interpretation of the gap which appears between 
experimental and clinical stem cell based TE approaches (bench-to-bedside), 
in principle, the future of stem cell based TE appears bright. But, considering 
as well the lengthy/costly clinical trials that are required for the translation of 
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stem cell research to cell therapeutics [47], more efforts in the preclinical stage 
aligned to the TE rising trend of biomimetic integrative research strategies 
[48-50], where multi-factorial experimental settings may closer resemble the 
in vivo scenario, may be needed to enhance translational impact and accelerate 
translation. Such integrative strategies use biofabrication techniques which 
incorporate biomimetic microarchitectures and physical/biochemical elements 
into a unified customizable manufacturing scheme [39, 48, 50-54].  
 
1.4. Design-driven 3D printing TE; A scaffolding TE technological 
approach able to merge Rationale I and Rationale II  
By delivering a high level of tunable control over the microarchitecture of 
a graft, 3D printing TE technology can control concurrently many design 
elements which affect the biofunctionalization ability and subsequently the 
overall regeneration capacity of a stem cell orthopedic graft. Thus, 3D printing 
technology appears able to extend its scope beyond the control of scaffold’s 
boundary geometry and serve ideally an integrated developmental research 
framework aligned to the recent trend of innovative scaffold designs, towards 
the optimization of the delicate and dynamic interplay of multiple factors 
affected from spatial features of the inner space of the graft [29, 45, 51].  
Four levels of architecture might be considered in such integrative design-
driven optimization studies namely surface topography, pore size and 
geometry, porous networks, and macroscopic pore arrangement, including the 
potential for spatially varied architectures [55].  
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These studies and respective CAD modellings [56], may streamline also 
evidence derived from non-3D printed TE studies relative to 
microarchitectural geometries which could act as inductive signals, like the 
porous size [57-59], the porous architecture [60], the design of functionally 
graded scaffolds (FGSs) where scaffold’s pores appear with changes in space 
according to a specific gradient [61], a microtubule-orientated scaffold with 
interconnected pores [38] and a microfluidics scaffolding network as structural 
guiding template within the scaffold for the formation of perfused vasculature 
[62, 63]. 
Furthermore, the design-driven optimization research trend appears well 
established, as current similar studies target innovative scaffold designs with 
microarchitectures able to optimize the interplay between often conflicting TE 
elements like biological and mechanical ones [64, 65]. Thus, it appears fair to 
say that 3D printing TE technology appears as the technology with the highest 
ability for the development of integrative design-driven optimization studies 
[44, 66], able to investigate novel geometrical features and new scaffold 
design concepts, in the strict context always of a clear research plan where the 
effects of the integrated geometrical parameters of the scaffold/graft are not 
mixed with each other [42].  
Additionally, the unique control engineering ability of the 3D printing 
technology, appears with a positive impact in the feasibility of an integrative 
design-driven optimization study. More particularly, the ability of 3D printing 
technology to deliver a high level of tunable control over the microarchitecture 
of a graft affecting multiple outputs (microarchitectural geometries which 
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could have an impact in physical factors), is being coordinated from a single 
input (CAD/STL file). This single input can be easily and continuously 
modified by feedback derived from CAD simulations and in-vitro experiments, 
by simply changing the design parameters of the CAD model. Accordingly, a 
clearly planned one-pot 3D printing TE study [52, 53] which targets the 
integrated design of a graft (single input), generates an optimum single-input 
multiple-output control engineering system able to be modified feasibly and 
continuously by feedback, towards the optimization of multiple factors that 
affect the regeneration capacity of the graft. 
 
1.5. A justified research target; Development of the prototype of an 
integrated 3D printed stem orthopedic graft 
Taken together as well the manufacturing limitations of the technology [39, 
53, 67, 68] which sets the printing resolution ability at the mesoscale [69], a 
3D printing TE study which similar to studies that focus in the computational 
design of the microarchitecture of a scaffold/graft [70-79], proposes a novel 
CAD pattern for the 3D printing biofabrication of an integrated stem cell 
orthopedic graft prototype, creating a design platform towards the further 
prototype to product development of a graft with ability for large scale 
personalised biofabrication and enhanced regeneration capacity, appears as a 
well justified research target. In this context, the “integrated” graft has been 
developed according to a very clear research plan where the effects of the 
geometrical parameters of the graft are not mixed with each other. The 
geometrical parameters of the graft consists of a bio-inspired scaffolding 
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micro-architecture and concurrently novel “form follows function” design 
micromechanisms in the design/manufacturing interface of 3D printing and 
microfluidics engineering. Subsequently, the prototype has been printed within 
the resolution limitations of the final product/graft, as usually the 3D printers 
for prototyping appear with higher resolution and manufacturing ability 
compared to those that they print functional scaffolds/grafts using FDA 
approved biodegradable/biocompatible materials (these are the materials that 
the current study suggests for the further prototype to product development of 
the graft). Finally, as also analysed above, in a manufacturing and clinically 
“friendly” direction, a non cell-laden 3D printing approach has been selected. 
This manufacturing approach is expected also to provide more rigidity in the 
graft, as the frame-added construct would be more effective for supporting its 
original printed shape compared to a graft comprised only from cell-laden 
hydrogels. Well justified recent studies [39, 80, 81] which similarly to the 




The goal of this design-driven optimization 3D printing TE study is to 
develop the prototype of an integrated stem cell orthopedic graft, through a 
novel 3D CAD pattern which targets the large scale personalized 
biofabrication ability and enhanced regeneration capacity of the graft, creating 
so a design platform for further studies towards the prototype to product 
development of the graft. The hypothesis is that in terms of commercialization 
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the minimal pattern size will allow the large scale personalized 3D printing 
biofabrication of the graft and in terms of biological significance, targeting a 
toolkit of microarchitecture-performance relations designed to enhance the 
regeneration capacity of the final integrated product/graft, the graft in the 
preliminary prototyping stage will appear able to control cell positioning on 
the graft and develop ability for vascularization, as well, ability for 3D cellular 





Following an integrative design approach in the strict context of a clear 
research plan, where the effects of the integrated geometrical parameters of the 
graft are not mixed with each other [42], this design-driven optimization study 
targets five clear objectives within an one-pot 3D printing manufacturing 
approach. The above setting targets the development of the prototype of a 
novel 3D printed integrated stem cell orthopedic graft, through a novel 3D 
CAD pattern designed to drive the large scale personalized biofabrication and 
enhanced regeneration capacity of the graft. Due to the limitations of the 3D 
printing technology, the five objectives have been hierarchically diversified 
from 1 to 5, based on the increased manufacturing complexity to achieve each 
one of them, as follows: 1. Biomimetic design, 2. Large scale personalized 
biofabrication, 3. Control of cell positioning on the graft, 4. Oxygen 
supply to the artificial stem cell niches and 5. Enhanced regeneration 
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capacity. Additionally, this study isolates a primary adipose-derived 
stromal/stem cell population and suggests a further developmental pipeline, 
creating a complete design platform towards the future prototype to product 
development of the graft. 
 
3.1. Objective 1: Biomimetic design 
 
Description and mechanism: A biomimetic design of the graft as it is 
depicted in fig. 4 comprised of two microfluidics networks: a) an osteo-
inductive microfluidics network with canals and porous (artificial stem cell 
niches) as biomimetic template to guide the organized cell positioning on the 
graft and b) a vascular-inductive microfluidics network as a guiding structural 
template for the formation of perfused vascular network (please see detailed 
description in methodology). The biomimetic microfluidics networks within 
the final model/graft is expected to function as a guiding structural template 
for the formation of mineralized clusters (MSCs/osteoblast’s niches) and 
perfused vessels similar to the natural bone tissue. 
 
Design rationale: Strong evidence [48, 71, 82-85] suggest a need for 
biomimetism (the process of simulating what occurs in nature) in TE studies 
and especially on the development of a vascularization network. Based on 
these studies, it is not clear to what degree we should mimic natural organs or 
tissues. However, it is certain that the biomimetic design may include spatial 
features designed to guide the development of vascular network, cellular 
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aggregates, nutrients and growth factors at the right time, right position and 
right amount. A recent review provides an overview of efforts and proposes 
future perspectives to engineer a functional vascular network [86]. It is needed 
to highlight also here recent studies where the authors developed pre-
vascularized TE scaffolds [1] and microfluidics scaffolding network within a 
TE scaffold as guiding template for the formation of perfused vasculature 
together with respective computational models for the optimization of the 
microarchitecture of the network [62]. 
More particularly relative to the design rationale for the development of a 
vascular network, the design approach so as to develop effectively a vascular 
network for bone regeneration applications, requires insights relative to the 
role of vascularization on bone regeneration. Thus, inadequate blood supply 
appears as a significant contributing factor for delayed fracture healing or non-
union, with inadequate oxygen supply to appear as the basic causative agent 
that impairs fracture healing (ischemia occurred often in the fracture area 
creates a local hypoxic microenvironment, especially within segmental 
ischemic fractures, which appears to lead in cell death and delayed 
chondrocyte and osteoblast differentiation) [41].  
Also, it appears fair to say that the different origin of the three cell types of 
skeleton with chondrocytes and osteoblasts derived from the mesenchymal 
origin and the osteoclasts derived from the monocyte-macrophage cell lineage 
[7], supports even more the need for a vascularization network able to bring 
together in the fracture area these distinct cell types. This combination of 
heterogeneous cells towards the mimic of the complex cellular environment 
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that occurs during bone healing, might increase the regenerative ability and in 
situ bone tissue morphogenesis [87].  
Experiments as well with non-vitalized TE grafts have shown that the 
resorption of these grafts depends on the existence of a local functional 
vascular network. Thus, the development of a functional vascular network 
may also have a beneficial impact in the biodegradation rate of the graft. [88] 
In order to define to what degree we should mimic nature for the 
development of a vascular network, considering the well justified role of 
hypoxia inducible factors (HIFs) [89], hypoxic environment appears as a 
conducive microenvironment for vascularogenesis [41, 88, 90]. A vascular-
inductive microenvironment in that case appears inversely related to the local 
oxygen tension [87, 91, 92]. Therefore, the biomimetic design of a vascular-
inductive network within a graft, implies the development of two individual 
biomimetic microfluidics networks, as following:  
a) 1st microfluidics network, an osteo-inductive microfluidics network with 
canals and porous (artificial stem cell niches) as guiding structural 
template to guide the organized cell positioning on the graft. The network 
has been designed to guide the induction of the MSCs to the osteoblastic 
lineage, targeting the formation of mineralized clusters (osteoblasts’ 
niches), which appears to need exposure to oxygen sources. An oxygen 
supply design micromechanism in that case, to address the needs for 
oxygen at the early inflammatory stage that vascularization has not yet 
developed, especially in the centre of the graft where the development of a 
functional vascular network appears with more delay, it appears as a well 
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justified research target (please see in the 4th objective of the current study, 
the air/oxygen trap design micromechanism).  
a) 2nd microfluidics network, a vascular-inductive microfluidics network as 
guiding structural template for the formation of perfused vascular network 
(please see detailed description in methodology). The network has been 
designed to guide the induction of vascularization (perfused vessels), 
which appears to need hypoxic conditions (the oxygen supply mechanism 
targets only the 1st microfluidics network). 
Taken together, a biomimetic spatial heterogeneity comprised of two 
individual microfluidics networks, drives the biomimetic design rationale of 
the 1st objective of the current study (fig. 4). Drawing a conclusion relative to 
the advantages of such a biomimetic microarchitectural structure of 2 
individual microfluidics networks, compared to a homogeneous 
microarchitecture (e.g. homogeneous lightweight scaffolding structures 
provided from commercial TE design software programs, carrying repeated 
parallel or cross motifs), so as to justify furthermore the biomimetic design 
approach of the current study, it appears to fit ideally to the purposes of this 
study the suggestion of a recent comprehensive study on bone TE [93], which 
indicates that when a TE scaffold has been designed for uniform distribution 
of biologics within the scaffold, this biofabrication approach does not appear 
optimum for the development of vascularization. Similarly, one more key 
study, suggests a spatial layering scaffolding technique which drives 
vascularization in defined areas in the context of VEGF-driven angiogenesis 
[54].   
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Therefore, similarly to the biomimetic microarchitecture of the current 
study, strong evidence indicates that scaffolding microarchitectures which 
allow spatiotemporal controlled delivery of various inductive factors and cell 
types, segregating the osteogenic from the vascularogenic signals, may result 
in improved vascularization outcome. 
 
3.2. Objective 2: Large scale personalized biofabrication 
 
Description and mechanism: The minimal pattern unit size 
(4mmX4mmX3.2mm) as it is depicted in fig. 4 and 6, similarly to the 
commercial “unit cells” provided from software providers, has been designed 
to allow easy scaling in the 3D printing biofabrication of the graft (scalable 
design).  
The heterogeneous/biomimetic design novelty of the pattern unit to scale 
up easily without affecting the integrity of the internal 
heterogeneous/biomimetic structure of the graft, so as to biofabricate grafts of 
various sizes homostructural to the lamellar structure of the natural bone and 
concurrently tailored to fit in any fracture area, is the design mechanism 
behind the development of ability for large scale personalized biofabrication 
of the graft.  
 
Design rationale: The lack of heterogeneous/biomimetic “unit cell” 
patterns within the libraries of software programs like the “Mimics” 
(Materialise) and “Grasshopper” (Rhino), which can be expanded easily so as 
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Fig. 2. Photo taken from [94]; microfluidics system with (a) an infusion design 
mechanism comprised of an inlet tube linked to the microfluidic networks 
which delivers the cells homogeneously to the network and (b) cell 
encapsulation technology which develops ability for cell aggregates. 
a b 
to develop a graft able to fill up with sufficient accuracy the void spaces of 
fracture gaps, resulted in the innovative idea for the development of an 
heterogeneous/biomimetic pattern unit (“unit cell”).  
Therefore, the novelty behind the developed pattern unit (“unit cell”) is 
that it appears with an heterogeneous/biomimetic scalable design compared to 
the already existed in the market homogeneous ones, which usually are 
comprised of parallel or crossed repeated motifs. 
 
3.3. Objective 3: Control of cell positioning on the graft 
 
Description and mechanism: Similarly to respective microfluidics 
systems (fig. 2) [94], two “form follows function” design micromechanisms 
adjusted to the 1st microfluidics network of the graft, designed to control the 
cell positioning on the final model/graft,  as follows:  
a) An infusion design mechanism comprised of an inlet tube linked to the 
microfluidics networks of the graft (fig. 2), which is expected to allow the 
feasible loading of the hydrogels on the graft (for visualization purposes, the 
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CAD model and the prototypes of the current study, do not include an infusion 
design mechanism linked to the 2nd microfluidics vascular-inductive network). 
b) A cell trap design mechanism as it is depicted in fig. 7 which similarly 
to existed microfluidics systems (fig. 2b) is comprised of narrow input-output 
interconnection canals of the porous (artificial stem cell niches). The design 
mechanism is expected to trap the cells in the pores following the interaction 
of the spatial configuration with the generated gravitational and fluid forces 
when the graft is infused with the stem cell hydrogel, developing so ability for 
3D cellular aggregation inside the pores. 
The combination of the above (a) and (b) mechanisms adjusted to the 
biomimetic microfluidics network in the final model/graft, is expected to 
control cell positioning on the graft, guiding the homogeneous distribution of 
the cells on the graft and concurrently developing ability for forced 3D cellular 
aggregation inside the pores. 
 
Design rationale: As described also in the literature review part, the 
manual injection of a scaffold/graft with a stem cell hydrogel, towards the 
biofucntionalization of the graft with stem cells, appears as a superior 
approach compared to the dripping protocol. But even though, experimental 
and clinical results indicate weakness of the technique to drive an 
homogeneous population of a scaffold/graft with cells. Accordingly, recent 
studies suggest further research work for the development of scaffolds/grafts 
with optimized biofunctionalization ability and respective techniques able to 
address the caveat [37, 95]. In this context, the proposed infusion mechanism 
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of the current study has been designed so as to address the caveat, driving the 
homogeneous distribution of the cells on the graft. 
Further, MSCs themselves appear to serve as a niche component. 
Subsequently, 3D MSCs aggregates may improve the therapeutic potential of 
stem cell applications through increased production of trophic factors, 
preserved stemness, improvements of ischemia resistance and increased 
retention and viability in vivo [96] [97] [87]. Respective design strategies 
targeting stem cells aggregation and cell patterning expanded to the third 
dimension have been reported also in other studies, targeting a spherical 
spatial boundary condition (SBCs) as a more conducive microenvironment to 
induce osteogenesis [98], a more in vivo-like multicellular spheroid structure 
similar to the structure of the in vivo three-dimensional (3D) stem cell niche 
[99], a stencil-based strategy to produce micro-Heart Muscle (μHM) arrays the 
geometry of which drives stem cell’s inherent self-organizing capability to 
generate a uniaxially-stressed substrate-anchored tissue [100] and ASCs 
cultures in spheroids which appeared with increased therapeutic potential 
[101].  
Taken together the combination of the infusion mechanism linked to the 
biomimetic microfluidics network and the cell trap design mechanism, the 
design rationale of the 3rd objective of the current study targets the control of 
the cell positioning on the graft, providing homogeneous distribution of the 
cells on the graft and concurrently forced stem cell (MSCs) 3D aggregation 




Fig. 3. Photo taken from [102]; microfluidic systems with oxygen control inserts. 
3.4. Objective 4: Oxygen supply to the artificial stem cell niches 
 
Description and mechanisms: Similarly to the design rationale of 
microfluidics systems that provide oxygenation to each well of a cell culture 
well plate using oxygen control inserts  (fig. 3) [102], a “form-follows-
function” air/oxygen trap design micromechanism adjusted to the 1st 
microfluidics network of the graft, comprised of smaller inner space of the 
pores lower to the height of the interconnection canals, compared to the inner 
space of the pores above the height of the interconnection canals 
(unproportional pores design). 
 
The air/oxygen design micromechanism has been designed to trap 
air/oxygen at the top of each pore, based on the interaction of the spatial 
configuration as described above with the fluid forces, following the infusion 
of the graft with the hydrogel (fig. 7). Subsequently, the gelation/solidification 
of the hydrogel will “lock” the air/oxygen at the top of each pore (the 
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suggested hydrogel for the further prototype to product development of the 
graft, is a hydrogel with physical cross-linking ability at 37oC, please see 
Chapter 8. - FUTURE STUDIES). Thus, the stem cells within each pore 
(artificial stem cell niches) of the graft will have access to air/oxygen so as to 
maintain cell viability and facilitate the creeping substitution even in the 
centre of the graft at the early inflammatory stage that vascularization has not 
yet developed 
 
Design rationale: It is well justified that micro-environmental oxygen 
tension has an impact on vascularization and fracture healing, so providing 
locally oxygen in ischemic fractures might lead in an optimized bone healing 
outcome [41]. More particularly, oxygen as a physical factor and signalling 
molecule appears to regulate the developmental growth of bone [103] and the 
fracture healing [41]. Thus, a solution to provide adequate oxygen within 
hypoxic conditions, appears as a justified research target in stem cell-based TE 
studies [104].  
In such studies, it is considered usually that the vascular damage that 
occurs within large bone injury, renders sites of bone defects ischemic. 
Delivering stem cells to the defect site within a stem cell based therapeutic 
approach, increases further the local metabolic demand and worsens the 
detrimental effects arising from the lack of adequate oxygen supply, as 
functional vascularization of a bulky orthopaedic graft may take weeks. Hence, 
in stem cell-based TE approaches, maintaining cell viability within this harsh 
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environment (absence of a functional vascular network), it appears as an 
imperative challenge.  
Respective studies suggest further investigation for more efficient 
strategies to maintain cell viability, mainly due to diffusion which appears as 
the primary mechanism in these cases for delivering oxygen and nutrients to 
the cells [37, 95]. Subsequently, within conventional stem cell TE 
scaffolds/grafts, many cells/tissues suffer from hypoxia and/or deprivation of 
nutrients, because it is well established that the diffusion length of oxygen and 
the maximum respective diffusion distance for cells seeded in a scaffold/graft 
as to survive in the absence of a functional vascular network, is less than 200 
µm. So, the central area of engineered tissues greater than 1 cm3 appears often 
hypoxic, resulting subsequently in imperfect tissues with a necrotic center and 
viable cells forming minimal tissue restricted to the graft’s boundaries. Thus, 
it is suggested that the cells must be localized within the indicated distance of 
the 200 µm from oxygen sources, to prevent hypoxia and necrosis [39, 85, 
105]. 
In aggregate, a design-driven optimization rationale for the development of 
novel scaffolds/grafts with enhanced “biofunctionalization” ability which will 
lead in more efficient seeding techniques, where the scaffolds -among others- 
will appear with enhanced diffusivity [106] and the cells will be able to 
withstand the oncoming hypoxic insult until new vessels have formed [37], 
appears as a justified design rationale. A well justified recent study verifies the 
design rationale of the current objective, targeting to ensure effective transport 
oxygen and nutrients to encapsulated cells within a microfluidics system [107]. 
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Accordingly, the proposed air/oxygen design micromechanism which 
constitutes the 4th objective of the current study, targets to provide adequate 
oxygen supply in the stem cells following the entrapment of air/oxygen at the 
top of each pore of the graft.. 
 
3.5. Objective 5: Enhanced regeneration capacity 
 
Description and mechanism: The synergistic effect of all the objectives of 
the current study is expected to affect beneficially the overall regeneration 
capacity of the graft, within future studies towards the further prototype to 
product development of the graft.  
 
Design rationale: All integrated studies described above target a beneficial 
synergistic effect based on the multi-factorial experimental setting of each 
study. 
 
4. Scientific significance  
 
By developing the prototype of an integrated 3D printed stem cell 
orthopedic graft, this novel study triggers the development of a toolkit of 
microarchitecture-performance relations designed to tailor the large scale 
personalised biofabrication ability and regeneration capacity of a graft. In 
terms of biological significance, the biomimetic spatial heterogeneity of the 
graft in the prototyping stage appeared with potential to control cell 
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positioning on the graft and guide vascularization. Additional “form-follows-
function” design micromechanisms in the design/manufacturing interface of 
3D printing and microfluidics engineering, appeared also with potential to 
develop ability for 3D cellular aggregation and oxygenation within the pores 
(artificial stem cell niches) of the graft, so as to maintain cell viability and 
facilitate the creeping substitution even in the centre of the graft at the early 
inflammatory stage that vascularization has not yet developed. The overall 
synergistic effect of the integrated design, especially within non-union clinical 
cases, is expected to enhance the overall regeneration capacity of the graft in 
the direction of a functional full-thickness bone healing outcome. Additionally, 
the study isolates a primary adipose-derived stromal/stem cell population and 
suggests a further developmental pipeline towards the further prototype to 




5.1. Design methodology 
 
Despite the fact that the microarchitecture of a graft appears to affect 
graft’s regeneration capacity, so as the design-driven optimization of the 
microarchitecture of a graft to be a justified research target [55, 61, 64, 65, 108, 
109], a single optimal microarchitecture does not exist. Microarchitectural 
optimized structures may be developed only on a case-by-case basis and 
accordingly to individual fracture-specific features [55]. Also, the link 
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between grafts’ microarchitecture and stem cell behavior is still far from being 
completely understood, so progress in the quantitative microarchitectural 
description of TE scaffolds is needed for the identification of the optimum 
graft microarchitecture, getting closer to design-driven optimized grafts [109].  
Accordingly, defining the optimal design for an integrated stem cell 
orthopedic graft, appropriate for transplantation and able to drive bone 
regeneration, is a complex process. In such studies, determination of the key 
factors affected from the microarchitecture design that appear to influence the 
regeneration capacity of the graft is being required. Design ideas and design 
mechanisms derived from biological systems or man-made devices, including 
microfluidics systems with cell encapsulation technology (fig. 2) [94], 
microfluidics systems within semienclosed space with multiple inlets [107] 
and “revolutionary” 3D printed microfluidics systems [102] that introduce 
oxygen control systems (fig. 3) [102] [110], could be also useful in such 
studies.  
More particularly, working on the design/manufacturing interface of the 
microfluidics systems and 3D printing TE technology, some of these 
microfluidics ideas, by compromising the structural integrity of the final graft, 
may be translated from the microfluidics to 3D printed scaffolds/grafts. 
Aligned to this rationale, this study targets “form-follows-function” 
microarchitecture design configurations of microfluidics systems which in 
addition with other variables that affect the flow rate, they have designed to 
allow the control of cell positioning on the system and to provide oxygen to 
the cells. A recent well justified study where they combined the direct 3D-
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printing of cell-laden constructs in microfluidic microarchitectures [111], is 
strongly indicative of the highly promising interplay between the 3D printing 
microfluidics engineering and 3D printing TE scaffolding biofabrication.  
Highly importantly also and as the aim of the current study is to develop 
the prototype of a novel graft so as to set the basis for future studies for the 
further development of the graft, it is needed to highlight here that despite the 
fact that the prototype has been printed with a commercial 3D printing system 
(Stratasys - Objet260 Connex1) and a respective proprietary 3D printing 
material (Stratasys - RGD720 transparent material) that provides relatively 
high resolution manufacturing ability >30 µm, the CAD model and the 
respective prototype outcome has been adjusted to the requirements and 
manufacturing limitations of the technology for printing biodegradable and 
biocompatible materials with an open extrusion/jet 3D printing system (this is 
the system that this study suggests for the future development of the graft), 
which implies orthogonal configuration in the design of the porous/canals and 
relatively low resolution ability > 200 µm. 
Therefore, an integrative design approach in the strict context of a clear 
research plan where the effects of the integrated geometrical parameters of the 
graft at the mesoscale (resolution >200 µm) are not mixed with each other [42], 
including literature evidence that suggests microarchitectural geometries and 
topological features conducive for TE bone regeneration applications, as well 
engineering inspiration derived from microfluidics systems, the lamellar 
structure of the natural bone and “form-follows-function” architectural 
29 
 
solutions for bioclimatic constructions, resulted in the development of the 
CAD model of the current study (fig. 4) and the respective prototype (fig. 6). 
 
5.2. CAD model 
 
The CAD model (fig. 4) of the pattern unit which for the reasons that 
analyzed extensively above incorporates two individual microfluidics 
networks within an all-in-one minimal pattern unit of 4mmX4mmX3.2mm, is 
comprised of the following quantitative microarchitectural design elements: 
1st microfluidic network (osteoinductive hydrogel): Infusion mechanism: 
Tube with 1 mm diameter which is linked to all infusion canals of the 1st 
microfluidic network. Infusion canal (“haversian” canal): “large” square canal 
(side of 1 mm) designed for high permeability as to avoid as much as possible 
the generation of shear stress on the cells and clogging effects during the 
infusion of the stem cell hydrogel on the graft, and subsequently, as to deliver 
homogeneously and with a consistent flow rate the stem cells even in the 
deepest areas of the graft, where there the cells will be distributed to all 
interconnection canal-porous canals of the graft. Exit canal (“haversian” 
canal): the same boundaries with the entry infusion canal but with different 
design rational, as in this canal there is no need for consistent flow rate, so a 
cross grid configuration has been added in the inner space of the canal 
designed to provide macroscale spatial features for the cells to adhere. Porous 
(artificial stem cell niches): according to the literature for optimum 
osteogenicity which implies a graft with side pore size between 300 µm - 
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800 µm [42, 57, 112] and considering as well the manufacturing limitations of 
the 3D printing technology, the pore has been designed with the dimensions of 
0.5mmX0.5mmX0.8mm. As analyzed in the objectives, the unproportional 
design of the pores relative to the interconnected canals, is expected to render 
porous as cell and air/oxygen trap mechanisms. Canal-porous and porous-
porous interconnection canals (“canaliculus”): these canals appear with the 
highest manufacturing difficulty as they have been designed with a side of 0.2 
mm which appears close to the resolution limitations of the suggested 
technology for the future prototype to product development of the graft (>0.2 
mm). 
2nd microfluidic network (vascular-inductive hydrogel): Infusion 
mechanism: Tube with 1 mm diameter identical to the infusion mechanism of 
the 1st microfluidic network, which is linked to the 2nd microfluidic network.  
For visualization purposes this second infusion mechanism is not included in 
the CAD model and the prototypes. Perforatory canals (“Volkman’s canal”): 
“Large” vertical canal (side of 1 mm) connected to the 2nd microfluidic 
network which as analyzed extensively in the objectives, it is expected to 
guide the formation of perfused vessels. 
 
5.3. CAD model evaluation - Computational flow simulation  
 
Computational flow simulation (SOLIDWORKS) has been applied in the 
CAD model of the pattern unit for the evaluation of the osteo-inductive flow 
path (1st microfluidics network) and the respective diffusion properties of the 
31 
 
unit. The experimental setting and the results are described in the materials 
and in fig. 5. For the 2nd microfluidics network at the current developmental 
stage of the prototype there is no need for computational flow simulation, as 
this network is comprised of simple linear canals, so the respective flow 
simulation as applied in the 1st microfluidics system, will not provide any 
useful information.  
 
5.4. Prototype model 
 
Three prototype models were printed as follows: 
a) Actual size visual prototype of the unit pattern. Considering as well the 
non-dissolvable properties of the supporting printing material which 
was used for the 3D printing of the prototype, the supporting material 
has remained within the graft to visualize the loading hydrogels (fig. 6). 
b) Scaled up X10 visual prototype of the unit pattern. Considering as well 
the non-dissolvable properties of the supporting printing material 
which was used for the 3D printing of the prototype, the supporting 
printing material has remained within the graft to visualize the loading 
hydrogels (fig. 6). 
c) Scaled up X25 functional prototype of the oxygen trap design 
mechanism where the supporting material has been removed (the X25 
scaled up model of the prototype allowed the extraction of the 
supporting printing material, by scratching the material with a pair of 
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forceps), so as to proceed further with an experimental flow simulation 
test (fig. 7). 
In the future prototype to product developmental studies of the graft 
which are suggested in details below (please see Chapter 8. FUTURE 
STUDIES), biodegradable/biocompatible 3D printing materials and 
dissolvable 3D printing supporting materials it is expected to allow the 
extraction of the supporting material from the graft, so as to proceed with 
the suggested evaluation tests using cell-laden hydrogels.   
 
5.5. Prototype morphology characterization - Evaluation of CAD to 
prototype model transition 
 
Top, bottom and side view images of the CAD model, the actual size 
visual prototype and the scaled up 10X prototype used for the morphological 
characterization (shape, structure and visualization of flow path) of the 
prototype models and the respective evaluation of the transition from the CAD 
model to structure (fig. 6).  
 
5.6. Prototype model evaluation - Experimental flow simulation  
 
Experimental flow simulation applied in the scaled up X25 functional 
prototype model of the oxygen trap design mechanism for the evaluation of 




5.7. Isolation of adipose derived stromal/stem cells  
 
White abdominal adipose tissue was harvested from freshly sacrificed 
rabbits in the MD2 animal facilities of NUS, using aseptic techniques. 
Following respective protocol where is described in details the procedure and 
concentrations of the reagents used [113],  the adipose tissue was proceeded 
further for the isolation of adipose derived stromal/stem cells. 
Briefly the protocol, the adipose tissue was minced into small pieces using 
sterilized scissors, washed with equal volumes of warm PBS containing 
EDTA, FBS and P/S, to remove blood cells and subsequently digested with 
collagenase type I with intermittent shaking at 37 oC for 60 min. The enzyme 
activity was terminated by dilution with DMEM containing FBS and the 
floating adipocytes were separated from the stromal cell fraction by adding 
slowly Ficol-Paque® and centrifugation at 300g for 25 min. The cells 
aspirated from the middle layer of the formed layers in the tube and incubated 
overnight at 37 oC with 5% CO2 in MSCs culture medium containing DMEM, 
Glutamax, FBS and P/S.  The isolated primary cells were cultured in T175 
flasks until they reached confluence and defined as passage zero. The 
nonadherent cells were removed 5 days after plating and the adherent cells 
allowed to proliferate in the expansion media until they reached 90% 
confluence. The confluent cells were subcultured up to passage 2 and the 
expansion MSCs medium was replaced every 3-4 days, so as after a cell 
culture of 3 weeks, to collect 4.22 X106 adipose derived stromal cell which can 
be used within future studies for the prototype to product development of the 
34 
 
graft (the cells cryopreserved in cryosolution and cryovials with 2X105 cells in 
each vial). The rest of the cells devided in three groups and proceeded for cell 
characterization according to a three lineages differentiation test [114, 115] 
which required 21 days of cell culture and differentiation induction. 
 
5.8. Differentiation induction of primary adipose derived stromal/stem 
cells 
 
Following respective protocol aligned to the three lineage differentiation 
test, where is described in details the procedure and the concentrations of the 
reagents used [114], the isolated cells devided into three differentiation 
induction cell culture groups and respective control groups. Following, the 
cells proceeded for 21 days of osteogenic, adipogenic and chondrogenic cell 
culture differentiation induction and subsequent histological and 
immunohistochemical analysis. The group 1 and 2 cultured in 24-well tissue 
culture plates according to osteogenic and adipogenic differentiation induction 
protocols respectively and the 3rd group cultured in 15 ml polypropylene 
screw-cap tubes where the cells were pelleted to form a 3D cell aggregate 
according to the chondrogenic differentiation induction protocol. Briefly the 
protocols: 
1st group - osteogenic induction: The isolated cells were plated at a 
density of 3×104 cells/cm2 on a 24-well tissue culture plate in MSC expansion 
media containing low glucose DMEM, FBS, P/S and Glutamax and allowed to 
adhere overnight at 37°C. The osteogenic differentiation induced by replacing 
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the MSC expansion medium with osteogenic media consisting of low glucose 
DMEM, FBS, dexamethasone, ascorbic acid, b-glycerophosphate, MEM 
sodium pyruvate, P/S and Glutamax. The control group of the cells was plated 
and maintained only in the MSC expansion media and all medium changed 
every 3 days for a period of 21 days. 
2nd group - adipogenic induction: The isolated cells were plated at a 
density of 6×104 cells/cm2 on a 24-well tissue culture plate in MSC expansion 
media containing low glucose DMEM, FBS, P/S and Glutamax and allowed to 
adhere overnight at 37°C. The adipogenic differentiation induced by replacing 
the MSC expansion medium with adipogenic media consisting of high glucose 
DMEM, FBS, P/S, Glutamax, insulin, isobutylmethylxanthine, sodium 
pyruvate, dexamethasone and indomethacin. Similarly to the osteo-inductive 
protocol, the control group was plated and maintained only in the MSC 
expansion media and all medium changed every 3 days for a period of 21 days. 
3rd group - chondrogenic induction: A cell density of 5 × 105 cells / ml 
was used and the cell pellets formed by aliquoting 0.5 ml of cell suspension 
into each 15 ml polypropylene screw-cap tube and subsequent centrifugation 
at 300×g for 5 min. The control cell culture medium consisted of high glucose 
DMEM, dexamethasone, L-proline, ascorbic acid, ITS+Premix, MEM sodium 
pyruvate, Glutamax and P/S.  For the chondrogenic differentiation medium, 
the TGFb3 growth factor added in the control medium. Three pellets were 
prepared for each group and the caps of the tubes were loosen during the 
incubation period in a 37oC incubator with 5% CO2 as to allow air exchange. 
The media was replaced every 2 days for a period of 21 days. 
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5.9. Characterization of primary adipose derived stromal/stem cell 
plasticity using morphological features - Optical microscopy, 
histological and immunohistological staining 
 
Following respective protocols aligned to the evaluation of the three 
lineage differentiation test [114, 115], after 21 days of cell culture, the cells 
were collected and proceeded for the evaluation of their plasticity, using 
morphological analysis of optical microscope images taken following the 
histological and histo-morphological staining of the cells. The results together 





CAD Model: The CAD models of the prototype and the respective STL 
files have been developed with the SOLIDWORKS and AUTODESK 123D 
DESIGN software programs. Prototype model: The prototype models have 
been printed using a Stratasys-Objet260 Connex1 3D printer and the 
respective RGD720 transparent material (Stratasys). Flow simulations: 
DMEM (Gibco/Invitrogen) cell culture medium was used in the experimental 
flow simulation and “water” in the computational one. Imaging: The images 
of the prototypes have been taken with an Olympus camera. Tissue 
harvesting – animal models: Two treatment-free freshly sacrificed New 
Zealand male rabbits were kindly donated from the MD2 animal facilities of 
37 
 
NUS for the adipose tissue harvesting. Stromal/stem cell isolation, culture 
and differentiation induction: Stromal/stem cells isolation: DMEM 
(Gibco/Invitrogen), FBS (Gibco/Invitrogen), GlutaMax-I Supplement 
(Gibco/Invitrogen), P/S (Gibco/ Invitrogen), TrypLE™ Express Stable 
Trypsin-Like Enzyme with Phenol Red (Gibco/Invitrogen), Ficol-Paque® (GE 
Healthcare). Osteogenic induction: DMEM low-glucose (Gibco/Invitrogen), 
FBS (Gibco/Invitrogen), GlutaMax-I Supplement (Gibco/Invitrogen), P/S 
(Gibco/ Invitrogen), Sodium pyruvate (Gibco/Invitrogen), ascorbic acid 
(Sigma), Dexamethasone (Sigma), b-glycerol phosphate disodium salt 
pentahydrate (Sigma). Adipogenic induction: DMEM high-glucose (4.5 g/L; 
Sigma), FBS (Gibco/Invitrogen), GlutaMax-I Supplement (Gibco/Invitrogen), 
P/S (Gibco/Invitrogen), Dexamethasone (Sigma), Insulin (Gibco/Invitrogen), 
Isobutylmethylxanthine (GMCN; Calbiochem/Merck), Indomethacin (Sigma). 
Chondrogenic induction: DMEM high-glucose (4.5 g/L; Sigma), GlutaMax-I 
Supplement (Gibco/Invitrogen), P/S (Gibco/Invitrogen), Sodium pyruvate 
(Gibco/Invitrogen), ITS+1 (BD Bioscience), Ascorbic (Sigma), L-Proline 
(Sigma), Dexamethasone (Sigma), Recombinant human transforming growth 
factor-beta3 (TGFb3) (R&D Systems). Stromal/stem cell histological and 
immunohistochemical evaluation: Osteogenic direction - Alizarin red 
staining: Formalin (Sigma), Alizarin red S (Sigma), Ammonium hydroxide 
(Sigma), Dulbecco’s Ca2+- and Mg2+-free phosphate-buffered saline (First 
Base). Adipogenic direction - oil red O staining: Oil Red O (Sigma), 
Hematoxylin (Sigma). Chondrogenic direction - fixation and paraffin 
processing: Formalin (Sigma), Eosin Y (Sigma), Xylene (VWR, International 
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S.A.S), Paraffin wax (Leica Biosystems), embedding machine (EG1160, Leica 
Biosystems), microtome (RM2135, Leica Biosystems). Hematoxylin and 
Eosin Staining: Hematoxylin (Sigma), Eosin Y (Sigma), Scott’s tap water 
(Sigma). Proteoglycan deposition - safranin O: Fast green (Sigma), Safranin 
O (Acros Organics). Collagen deposition - immunohistochemical detection: 
UltraVision HRP Detection System (Lab Vision Inc.) containing Ultra V 
Block, Biotinylated Goat Antimouse IgG, Streptavidin Peroxidase, 
Diaminobenzidine (DAB) substrate, and DAB Chromogen, Pepsin (Lab 
Vision), Hydrogen peroxide block (Lab Vision), Monoclonal anticollagen type 




7.1. CAD model – biomimetic scalable design 
 
The biomimetic and scalable CAD model captured and developed for the 
purposes of the 1st and 2nd objective of this study is depicted in the following 
fig. 4. As analysed extensively above, the heterogeneous/biomimetic minimal 
pattern unit size (4mmX4mmX3.2mm) which incorporates two individual 
microfluidics networks (osteo-inductive network with canals and porous and 
vascular-inductive network only with canals), allows easy scaling towards the 
3D printing biofabrication of the graft (scalable design), without affecting the 
integrity of the internal heterogeneous/biomimetic structure of the graft 
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Fig. 4. Biomimetic scalable design. (a) Microscopic view of the lamellar structure 
of the natural cortical bone 
(http://classes.midlandstech.edu/carterp/Courses/bio210/chap06/lecture1.html) 
and (b, c, d) respective biomimetic CAD models of various sizes of the graft 
(blue-green transparent colour) where is depicted the biomimetic design of the 
graft (haversian system, volkmann’s canals, canaliculus and osteoblasts’ 
mineralized niches), the infusion design mechanism (inlet tube) linked to the 
artificial stem cell niches hydrogel and the visualization of the 2 individual 
microfluidics networks designed to guide the infusion of the osteo-inductive 
(pink opaque colour) and vascular-inductive (red opaque colour) loading 
hydrogels; (b) From left to right: (i) 1X unit graft (pattern unit) loaded with both 
hydrogels, ii) visualization of both loading hydrogels and iii) 1X unit graft, (c) 
From left to right: i) visualization of both loading hydrogels in a 6X units graft 
and ii) the 6X units graft without the infusion mechanism (tube) for a clearer top 








(currently in the market are only provided homogeneous “unit cells”, 
comprised usually of parallel or crossed repeated motifs) .  
Therefore, the novel 3D CAD pattern unit depicted here appears able to 
allow the future large scale personalized 3D printing biofabrication of the graft, 
as well, it provides a structural guiding template to control cell positioning on 
the graft and guide vascularization, towards the further prototype to product 
development of the graft. 
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Fig. 5. Proof of concept for the flow path and the cellular and oxygen trap design 
mechanisms based on computational flow simulation; (a) Scale (human fingers) 
and high contrast photo of the 10X scaled up visual prototype of the pattern unit 
(transparent material) loaded with the supporting 3D printing material (opaque 
material) which visualizes the flow path of the loading hydrogels. (b) Computer 
screen photo of the computational flow simulation of the pattern unit 
(continuous flow all over the graft with white spots on the top of each pore and 





7.2. Computational flow simulation – proof of concept for the flow path 
and the cellular and oxygen trap design mechanisms 
 
The computational flow simulation test of the current study (fig. 5b) 
appears as a proof of concept evidence for the developed CAD model and 
respective prototype, as it verifies the design rationale behind the flow path 
and the diffusion properties of the graft.  
More particularly, the computational flow simulation (fig. 5b) appears 
continuous and aligned to the flow path of the prototype (fig. 5a), with 
homogeneous distribution of the flow chart (hydrogel) to all interconnected 
canals/pores, white colour areas at the top of the pore where is expected the 
entrapment of air/oxygen bubbles (air/oxygen trap design micromechanism) 
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and condensed flow in the centre of each pore where is expected the 3D 
cellular aggregation (cell-trap design micromechanism).   
Therefore, similarly to the technology in microfluidics which develop 
systems able to encapsulate cells and provides air/oxygen at the top of each 
well in a cell culture plate (fig. 2 and 3), it appears with potential the 
entrapment of cells and air/oxygen inside the pores, developing so ability for 
3D cellular aggregation and oxygenation within the pores (artificial stem cell 
niches) of the graft. 
 
7.3. Prototypes - evaluation of the transition from CAD model to 
structure 
 
In respective photos within fig. 6 from the top view (a, d, g), bottom view 
(b, e, h) and side view (c, f, i) of the 3D printing outcome-transition from 
CAD model to structure (left to right), the generated visual prototypes 
appeared with a good level of agreement compared to the CAD model, 
especially relatively to the intricate manufacturing details of the narrow 
interconnected canals and the unproportionally shaped porous which develop 
the cell and air/oxygen design micromechanisms (e, f, h, i).  
As it was expected, between the 10X scaled up pattern unit visual 
prototype and the actual size visual prototype, the scaled up prototype appears 
with a more consistent structural integrity and uniform flow path. The results 
appear encouraging for future studies for the further prototype to product 
development of the graft, where is expected a lower level of agreement 
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Fig. 6. Evaluation of the transition from CAD model to structure. Optical 
comparison of the CAD model of the X1 unit graft (pattern unit) with the 
respective actual size and X10 scaled up visual prototypes; (a, b, c) CAD model 
of the pattern unit (transparent blue colour) loaded with the 2 types of hydrogels 
where the flow path of the osteogenic stem cell hydrogel has been visualized 
with pink opaque colour and the vascularization hydrogel with red colour, (d, e, 
f) photos with scale (human fingers) and the 10X scaled up visual prototype of 
the pattern unit (transparent material) where the supporting 3D printing material 
(opaque black material) visualizes the flow path of the loading hydrogels, (g) 
photo with scale bar (10 cents coin) and the actual size visual prototype of the 
pattern unit, (h, i) magnified detailed photos of the actual size visual prototype of 
the pattern unit (transparent material) where the supporting 3D printing material 
(opaque pale white material) visualizes the flow path of the loading hydrogels.  
 
g d a 
b e h 
i f c 
between the CAD model and the final model/graft (with the current available 
technology, lower resolution ability it is expected when will be used the 3D 
printing systems / materials that the current study suggests for the further 
prototype to product development of the graft). 
 
7.4. Experimental flow simulation - Proof of concept for the oxygen 






Fig. 7. Proof of concept for the air/oxygen trap design micromechanism based on 
optical evaluation of a flow simulation in the 25X scaled up functional prototype 
of the design mechanism; (a) from left to right: i) CAD model of the design 
micromechanism (blue transparent colour) designed for air/oxygen entrapment 
and visualization of the loading stem cell hydrogel (pink opaque colour), ii) 
visualization of the loading stem cell hydrogel (pink opaque colour) and the 
trapped air/oxygen at the top of each pore (green transparent boxes at the top of 
each pore), iii) CAD model of the mechanism , (b) side view of the 25X scaled 
up functional prototype of the design micromechanism, where are depicted the 
spatial configurations (design micromechanisms) designed to trap air/oxygen 
inside the pore (the design micromechanism consists of smaller inner space of 
the pores lower to the height of the interconnection canal compared to the inner 
space of the pores above the height of the interconnection canal), (c) cell growth 
media (red colour) was used for a flow simulation of the air/oxygen trap design 
micromechanism using the 25X scaled up functional prototype and (d) Photo 
taken following the fulfillment of the liquid carrier; scale bar (10 cents coin) and 
the cell media appears to fully cover the design micromechanism, while the top 
of the inner space of the pores appear with trapped air/oxygen bubbles (white 
areas at the top of each pore) following the infusion of the cell media through the 
25X scaled up functional prototype (the media fully covered the prototype). 
 
The experimental flow simulation test of the current study (fig. 7), appears 
as a proof of concept evidence for the air/oxygen trap design micromechanism, 
as it verifies the design rational behind the “form-follows-function” design 
micromechanism, designed to trap air/oxygen at the top of each pore following 




The results of the experiment which appeared promising are analysed in the 
figure 7.  
Therefore, similarly to the technology in microfluidics which develop 
systems able to provide air/oxygen at the top of each well in a cell culture 
plate (fig. 3), it appears with potential the entrapment of air/oxygen at the top 
of the pores of the graft following the infusion of the osteo-inductive hydrogel, 
developing so ability for oxygenation within the pores (artificial stem cell 
niches) of the graft. 
 
7.5. Primary adipose derived stromal/stem cells plasticity 
 
The differentiation potential of the primary adipose derived stromal cells 
so as to be used in future studies towards the further prototype to product 
development of the graft, was evaluated with imaging & histo-morphological 
analysis according to respective protocols of the three lineage differentiation 
test [114, 115]. In the 21st day of the culture, representative triplicates from the 
differentiation induction and non-differentiation induction groups (cell culture 
in 24-well tissue culture plates for the osteogenic/adipogenic groups and cell 
pellet culture for the chondrogenic lineage) were isolated, fixed and proceeded 
for staining, histological and immune-histochemical staining and imaging. 
Relative to the morphological characteristics of the cells cultured in the 
24-well tissue culture plates (fig. 8), the cells appeared with spindle cell shape 
in all groups and formation of lipid droplets in the differentiation group of the 
adipogenic lineage (fig. 8d and 8f). Relative to the staining results, the cells 
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Fig. 8. Evaluation of the cells plasticity. Optical microscope photos for qualitative 
evaluation of the differentiation potential of adipose derived rabbit MSCs towards 
the osteogenic (a, b) and adipogenic direction (c,d,e,f) after 21 days of culture. 
Osteogenic direction; mineralization detection with moderate to strong alizarin 
red staining was observed in the differentiation group (b) compared to the control 
(a). Adipogenic direction; formation of cytoplasmic lipid droplets with fade oil 
red O staining (d) and without staining (f) was observed in the differentiation 
group compared to the control (c and e respectively). Magnification 20X. Scale 
bars: 200 um (a,b,c,d) and 100 um (e, f). 
a c e 
b d f 
appeared with moderate to strong alizarin red staining intensity towards the 
osteogenic direction (fig. 8b) and almost with no staining of the formed lipid 
droplets (fig. 8d) compared to the control groups (fig. 8a and 8c respectively) 
towards the adipogenic direction.  
Relative to the staining results of the cells cultured in cell pellets (fig. 9), 
cells appeared with conflicting evidence as the immunohistochemical Col II 
staining appeared strong (fig. 9b) compared to the control group (fig. 9a), but 
the proteoglycan’s safranin-O with fast green counter (fig. 9d) and the H&E 
staining for nucleus and cytoplasm (fig. 9f) appeared weak compared to the 
control groups (fig. 9c and 9e respectively). The above observations indicate a 
representative cellular phenotypic evidence of a mesenchymal stem cell (MSC) 




a c e 
b d f 
Fig. 9. Evaluation of the cells plasticity. Optical microscope photos for qualitative 
evaluation of the differentiation potential of adipose derived rabbit MSCs towards 
the chondrogenic direction after 21 days of culture; Strong brown 
immunohistochemical Col II staining was observed in the differentiation group (b) 
compared to the control (a). Fade red (red colour – green background) 
proteoglycan’s safranin-O with fast green counter staining was observed in the 
differentiation group (d) compared to the control (c). More intense purplish blue 
and red H&E staining for cell’s nucleus and cytoplasm respectively was observed 
in the differentiation group (f) compared to the control (e). Magnification 20X. 
Scale bar: 200um. 
 
More particularly, relative to the osteogenic induction result (fig. 8a and b) 
and the potential use of the isolated cells in future studies for the prototype to 
product development of the graft, the staining evidence suggest a relationship 
of the cells to osteogenic induction. But, the spindle-like shape of the cells 
which does not appear so sharp as to strongly indicate an “osteoblastic” 
morphology (a strong indication of the cellular phenotype of the osteoblasts is 
apparent) and, most importantly, the moderate to strong intensity of the 
alizarin red staining, appear as insufficient evidence to predict the final 
cellular state, confirming a strong osteogenic differentiation ability of the cells.  
Therefore, drawing a conclusion towards the characterization of the cells 
and the use of them in future studies for the further prototype to product 
development of the graft, the cells as a relatively homogeneous MSCs 
47 
 
population with moderate differentiation ability can be used in future studies 
efficiently for the evaluation of the cell positioning on the graft, by tracking 
the cell positioning on the graft following the infusion of the cells on it. But 
for further use and the purpose of the evaluation of the regeneration potential 
of the graft, where a robust cell line is needed with verified high osteogenic 
potential, the cells previously must undergo some purification of the 
population using flow cytometry, which could provide a more homogeneous 
and robust population. Alternatively, some other more robust market cell line 
can be used. 
 
8. Future studies 
 
Overview 
In principle, future design-driven optimization studies are needed to link 
grafts’ microarchitecture and cell behavior, providing quantitative 
microarchitectural reasoning for the design of TE scaffolds/grafts [109]. More 
efforts are needed towards the parameterization [116] of these studies as to 
provide key structural criteria for the design of the microarchitecture of a TE 
scaffold/graft. Co-axial studies with the current study on the computational 
microarchitecture design and the printing of a graft with more than one type of 
printing materials, may target as well programmable bilayer scaffolding 
microarchitecture patterns in space and time (4D printing) [117]. 
Considering as well the incremental nature of the scientific progress 
especially towards the development of novel “from scratch” research projects 
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like the current study, this study additionally isolates a primary adipose-
derived stromal/stem cell population and suggests a further developmental 
pipeline, creating a complete design platform towards the future prototype to 
product development of the graft. 
In particular, this study suggests the following detailed experimental setup 
for the continuation of the development of the graft: 
 
Methods 
Biomechanical evaluation of the scaffold (degradation, rheological 
properties and hydrophilicity): When the functional prototype will be 
printed, an evaluation protocol for the degradation rate [38], rheological 
properties [81] and the hydrophilicity [118] of the graft is suggested. 
Tracking cell positioning - seeding efficiency: The evaluation of the 
seeding efficiency (cell numbers and distribution throughout the scaffolds) is 
been suggested by using qualitative manual histological [37] and automated 
image analysis with ImageJ software program based on the fluorescence 
intensity (mean relative fluorescence intensity - RFI) of each sample group, on 
images taken by semi-automated microscopy following eGFP transduction of 
the seeded cells [37]. 
Evaluation of oxygen supply: EPR oximetry is been suggested for the 
direct measurement of tissue pO2 [119]. 
In vitro evaluation of the osteogenic capacity of the scaffold: A 
combination of protocols which include the cck8, alizarin red and ALP 
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activity tests [81, 120] is been suggested for the in vitro evaluation of the 
cytocompatibility and osteogenicity. 
Evaluation of vascularization: The quantified assessment of newly 
formed vessels on the graft is been suggested using eosin counterstained 
cryocuts and subsequent histomorphological imaging and analysis according 
to respective protocol [37].  
In vivo evaluation of the osteogenic capacity of the scaffold: According 
to in vivo protocols from respective studies [39, 121], four groups of rabbit 
animal model is been suggested as to evaluate the in-vivo regeneration 
capacity of the graft, as following (the groups): 
1. Untreated defect.  
2. Scaffold-only treated.  
3. Scaffold infused with stem cells. 
4. Commercial available product. 
More particularly, the selection of the commercial available product can be 
decided in a later time as a more advanced product might be launched in the 
market in the near future. In total, 4 groups is suggested (6 animals will 
represent each group, so the IACUC protocol will include 24 rabbits). 
According to the degradation rate of the PLGC block copolymer which is a 
material that is been suggested from the current study as the basis of the 
printing material for the further development of the graft (in the literature, the 
biodegradation rate of the PLGC appears to match the bone regeneration rate 
of up to 12 weeks), the rabbits can be sacrificed after 12 weeks. A 
combination of respective protocols [41, 121] for histological, 
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histomorphometrical and molecular analyses of the fracture healing is 
suggested.  
 Relative to the engraftment procedure, following adjustments in a 
suggested respective protocol [121], in rabbits’ femoral bones from six 
animals of the groups 2 and 3, cylindrical scaffolds with (approximately) 
diameter of 2 cm and thickness of 1 cm can be implanted for about 12 weeks. 
It is expected that the graft will degrade mainly by hydrolysis while bone 
regeneration and biomineralization process gradually progresses (creeping 
substitution). The expected graft swelling following the implantation of the 
graft will be a desirable result as it will provide an adequate press fit between 
bone graft and host bone tissue. 
 
Materials 
Relative to the 3D printing materials, it is strongly suggested the prototype 
to product development of the graft and the respective 3D printing of the 
functional prototype and final model/graft, to be continued with an open 
extrusion/jet 3D printing system (e.g. RegenHU Bioprinter Biofactory), using 
as a basic printing material (following tests) an optimized mixture of the FDA 
approved biodegradable PLGC block copolymer (PLLA-co-PGA-co-PCL), 
the degradation rate of which has been tailored to match the bone regeneration 
rate of up to 12 weeks [25, 122] and Pluronic F127 as supporting sacrificial 
material [39]. The increase of the quantity of PCL in the mixture as to enhance 
the printability of the ink can be considered [123, 124], as PCL is a flexible 
TE material for standalone biofabrication and subsequent coating surface like 
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chitosan [125], as well for the development of composite materials with other 
synthetic [126] or natural [127] TE materials. Highly importantly PCL appears 
with properties that makes it one of the most suitable materials for 3D printing; 
low melting temperature (60 °C) and rapid cooling after extrusion [39]. Highly 
importantly also, when PCL is used as a printing material, no physicochemical 
changes to the PCL are expected caused by the printing-jetting process [128]. 
The mixture of hydroxyapatite (HA) in the PLGC copolymer can be also 
considered, as its addition is expected to increase the printability and the 
mechanical properties of the graft [129, 130], as well, its osteoconductive 
properties will provide a substrate for the stem cells to adhere and differentiate 
(the mechanotransduction pathway appears critical for MSCs differentiation to 
the osteoblastic lineage) [29]. In case that finally a RegenHU printer will be 
used for the 3D printing of the functional prototype and the final 
model/product, the osteoconductivity of the graft can also be enhanced with 
the mixture of the “osteoink” printing material in the above copolymer, which 
is a standardized commercial osteoconductive material provided from 
RegenHU. 
Relative to the stem cell hydrogel, physically crosslinked hydrogels that 
gel spontaneously under physiological conditions in the temperature of the 
human body [131], they are suggested to constitute the basis for the 
development of the 2 microfluidics’ composite hydrogels. Various cell 
numbers and concentrations of each component can be tested for the 
development of the composite hydrogels, mainly consisted of gelatin, 
fibrinogen, hyaluronic acid (HyA) and glycerol mixed into DMEM (high 
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glucose). This composite has already tested in previous studies and a good 
indication of the optimum cell density is been provided [15]. Further 
optimization of the flow rate, the dispensing uniformity, the mechanical 
properties (before and after cross-linking with thrombin) and the cell viability 
will be required. For the 1st microfluidics network (osteo-inductive network), 
the respective hydrogel is suggested to be incorporated with MSCs. For the 2nd 
microfluidics network (vascular-inductive network), the respective hydrogel is 
suggested to be incorporated with VEGF, MSCs, heparin and endothelial cells 
[90, 132-135].  
 
Avoid pitfall strategy 
The experimental design of this study as well of the subsequent suggested 
studies for the prototype to product development of the graft, frame a single-
input multiple-output clear investigation plan of five independent objectives, 
in the strict context where the effects of the integrated geometrical parameters 
of the graft are not mixed with each other. The objectives have been classified 
and aligned to a five grade hierarchical diversification climax, based on 
increased manufacturing complexity/difficulty. The above setting provides the 
adequate flexibility in the implementation of future studies, as it allows the 
possibility to decrease the number of the objectives without affecting the 






A significant amount of evidence [29, 136-138] indicates that mechanical 
environment (mechanical loading type and magnitude) affects bone 
regeneration. So, as to avoid a multivariable experimental approach in the 
current study at the prototyping stage, the generated strain mechanical forces 
will be considered as experimental constant and the future prototype to 
product development studies may proceed as well in this way.  
I mention here that in this direction and as mentioned at the beginning of 
this study, the manufacturing “friendly” approach to print the graft with a non 
cell-laden hydrogel, so as the biofunctionalization of the graft with the stem 
cells to occur following the manual injection of the graft with the stem cells, it 
is expected to provide rigidity to the final model/graft, as the frame-added 
construct would be more effective for supporting its original printed shape 




The 2nd objective of the study has a clear commercial orientation as it 
targets the large scale personalized biofabrication of the graft. 
  
11. Conclusion  
 
New integrated design-driven optimization approaches not hindered by the 
limited capabilities of 3D printing technology may be needed to enhance 
translational impact in the research field of 3D printing Tissue Engineering.  
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In this context, by developing the prototype of an integrated 3D printed 
stem cell orthopedic graft according to a clear research plan where the effects 
of the geometrical parameters of the graft are not mixed with each other, this 
novel study argues the value of the integrated design-driven optimization 
perspective, triggering the development of a toolkit of microarchitecture-
performance relations designed to tailor the large scale personalised 
biofabrication ability and regeneration capacity of the graft. The integrated 
design of the graft consists of a bio-inspired scaffolding microarchitecture and 
concurrently “form-follows-function” design micromechanisms in the 
design/manufacturing interface of 3D printing and microfluidics engineering.  
Additionally, this study isolates a primary adipose-derived stromal/stem 
cell population and suggests a further developmental pipeline, creating a 
complete design platform towards the future prototype to product development 
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